HaoYue Capital
浩悦资本
elsewhere's corpus does not cover HaoYue Capital beyond the name itself — there's an entity card but no reporting attached to it. The articles retrieved alongside it are all about a different firm, Heart Capital (心资本), an early-stage Chinese tech VC founded in 2022 by former Lightspeed China partners , so they can't be used to describe HaoYue. If you meant Heart Capital or one of the other funds listed (Maxceed, Boyuan, Puquan, Qianyue), try searching those names directly.
AI-generated — may contain errors, please verify.
Coverage
Dalton Venture Wins Eight Awards from Joy List, Touzijia and Qimingpian for Biotech, AI Medical Breakthroughs, Innovative Devices, Life Sciences, Best Early-Stage Investment Institution and Healthcare Investment Institution
Recently, the winners of three major rankings were announced: the 10th Healthcare Investment Excellence Awards, the **Touzijia** 2025–2026 Fund Partner Rankings, and the Qimingpian 2026 Mid-Year China Equity Investment Rankings. Across the three lists, **Ning Huang, founding partner of Dalton Venture, was named to the Best Early-Stage Investor TOP 25, while Dalton Venture was recognized as Best Biotech Investment Firm, Best AI Healthcare Breakthrough Investment Firm, Best Innovative Medical Devices and Life Sciences Investment Firm, and...
BlueRun Ventures Portfolio Company Tian Cheng Technology Closes Another 100-Million-Yuan B+ Round to Accelerate the "Human-Machine Fusion" Era of Exoskeleton Consumerization | BlueRun Family
Making the leap from "rehabilitation tool" to "enhancement partner."
5Y News | QLT Biotherapeutics Raises Over 500 Million RMB in Series C Funding
Zhitai Biotech Closes Over 500 Million Yuan Series C Round to Accelerate Core Clinical Pipeline Development
Qiming Venture Partners Weekly | Portfolio News and Updates Vol. 32, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Venture Partners and Portfolio Companies Win Multiple Awards at 2029 Healthcare Investment Excellence Awards
The Healthcare Investment Excellence Awards have served as an important barometer for assessing corporate market value and institutional brand influence in the healthcare investment industry. Since their inaugural release in 2017, the awards have recognized investment institutions, investors, and healthcare companies with outstanding performance and distinguished contributions each year.
FreeS Fund China-US Venture Forum Session 2 is still open for registration; FreeS Fund receives multiple recognitions from Langchao New Consumption, Joy Capital, and Qiming Technology & New Voice Innovation Service
Do what's right, not what's easy.
